Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Roche Media News
Get the latest updates from Roche Media News directly as they happen.
Follow now 314 followers
Latest posts
Last updated 6 days ago
European Commission approves Roche’s Columvi as the first bispecific antibody for diffuse large B-cell lymphoma after initial therapy
6 days ago
Approval based on Phase III STARGLO study where Columvi in combination with...
Roche presents novel therapeutic and diagnostic advancements in Alzheimer’s at AD/PD 2025
17 days ago
New trontinemab data continue to support rapid and deep, dose-dependent reduction of...
Roche provides update on Phase III OCREVUS high dose study in people with relapsing multiple sclerosis
17 days ago
MUSETTE trial was designed to determine whether a higher dose of the...
Roche Annual General Meeting 2025
26 days ago
Shareholders approved all proposals of the Board of Directors Severin Schwan was...
Roche to share latest scientific advancements from its neuromuscular portfolio at Muscular Dystrophy Association (MDA) 2025 conference
about 1 month ago
New Evrysdi five-year data from the SUNFISH study showed continued stabilisation of...
Roche enters into an exclusive collaboration & licensing agreement with Zealand Pharma to co-develop and co-commercialise petrelintide as a potential foundational therapy for people with overweight and obesity
about 1 month ago
Agreement allows for a range of potentially best-in-class therapy options as monotherapy...
Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard’s Enterprise Research Campus in Allston
about 1 month ago
The new center will be a hub for both Roche and Genentech...
FDA accepts supplemental Biologics License Application for Roche’s Gazyva/Gazyvaro for the treatment of lupus nephritis
about 2 months ago
Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody in a randomised phase III...
Phase III study shows Xolair may be more effective with fewer side effects than oral immunotherapy for the treatment of food allergies
about 2 months ago
First-ever head-to-head trial comparing Xolair and oral immunotherapy (OIT) Results were featured...
CHMP recommends EU approval of Roche’s Columvi combination for people with relapsed or refractory diffuse large B-cell lymphoma
about 2 months ago
Columvi plus chemotherapy showed a 41% reduction in the risk of death...
Roche unveils a new class of next-generation sequencing with its novel sequencing by expansion technology
about 2 months ago
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in...
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
2 months ago
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in...